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What is already known? 
• Those born with a low birthweight may be “programmed” for vascular and metabolic 
disease in later life 
• When such individuals are exposed to additional stresses, they may manifest 
vascular/metabolic diseases  
• Pregnancy may act as a “second hit” for those who are programmed for future vascular 
and metabolic disease 
 
 
What does this study add? 
• Women who reported a low birthweight were at increased risk of major pregnancy 
complications  
• This large study confirms previous evidence that for those born with a low birth weight, 






















Objective: We investigated the influence of birthweight on the risk of pregnancy 
complications including preeclampsia (PE), gestational hypertension (GH), small for 
gestational age (SGA) pregnancy, spontaneous preterm birth (sPTB) and gestational diabetes 
mellitus (GDM) and assessed the effect of early pregnancy BMI on the above relationship.  
 
Methods: 5336 nulliparous women from the SCOPE study were included.  Women’s 
birthweights were self-reported and confirmed via medical records when possible. A 
birthweight of 3000-3499g was considered the reference. 
 
Results: After adjusting for confounders, birthweight <2500g was associated with increased 
risk of GH (aOR=2.2, 95% CI=1.3-3.7), preeclampsia (aOR=1.7, 95% CI =1.0-2.9), SGA 
(aOR=1.9, 95% CI=1.1-3.2) and GDM (aOR=2.4, 95% CI=1.0-5.8) compared to the referent. 
Women born with a birthweight <2500g and subsequently became overweight or obese were 
at increased risk of GH (aOR=2.2, 95% CI=1.1-4.5), preeclampsia (aOR=2.3, 95% CI=1.2-4.5) 
and GDM (aOR=3.2, 95% CI=1.1-9.5), compared to women who were born with a birthweight 
≥2500g and remained lean. 
 
Conclusion: Women who were born with a low birthweight are at increased risk of pregnancy 
complications. Those born small may have undergone “programming” in response to 
unfavourable intrauterine conditions. In such women, the physiological demands of pregnancy 










The intrauterine environment is recognised as a crucial determinant of later life disease 
susceptibility since the original theory was proposed in the 1990’s (1). The fetal origins of adult 
disease hypothesis was first described by David Barker, who proposed that disruptions to the 
intrauterine environment during fetal development can ‘program’ for increased risks for 
diseases in adult life (1). Subsequent epidemiological studies confirmed this hypothesis 
showing strong evidence associating low birthweight with increased vulnerability to a myriad 
of adult life vascular and metabolic diseases including hypertension, cardiovascular disease, 
stroke and type 2 diabetes mellitus (1-4). 
Some individuals who are “programmed” for increased disease risk develop chronic diseases 
despite healthy environmental and lifestyle effects which may be due to genetic predisposition, 
whereas others develop disease only when exposed to a “second hit” (5). These “second hits” 
are often adverse lifestyle factors i.e. smoking, unhealthy diets and sedentary lifestyles (5). 
Pregnancy is increasingly being recognised as a common “second hit” for females (5). 
Pregnancy is considered a physiological stress test for the female cardiovascular system which 
undergoes many physiological changes during pregnancy to meet the demands of the growing 
fetus (5). Women who successfully “pass” the test have uncomplicated pregnancies while those 
who “fail” may experience adverse pregnancy outcomes. Therefore, women who were born 
small when exposed to the “second hit’ of pregnancy may experience pregnancy complications. 
The primary aim of this study was to examine the influence of maternal birthweight on the risk 
of development of pregnancy complications including preeclampsia (PE), gestational 
hypertension (GH), small for gestational age (SGA) pregnancy, spontaneous preterm birth 
(sPTB) and gestational diabetes mellitus (GDM). Those born small have a tendency to become 
overweight/obese in adulthood (6). Therefore, we also assessed whether maternal 
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overweight/obesity had an impact on the association between maternal birthweight and 
pregnancy complications.  
 
MATERIALS AND METHODS 
 
The participants of this study were women who were recruited to the SCOPE study between 
November 2004 and February 2011 in Adelaide, Australia, Auckland, New Zealand, 
Manchester, Leeds and London, United Kingdom and Cork, Ireland.  The SCOPE study 
(www.scopestudy.net) is an international, multicenter, prospective cohort study with the aim 
of developing screening tests to predict preeclampsia, SGA infants and spontaneous preterm 
birth across different populations. Ethics approval was gained from local ethics committees of 
each participating center (Australia REC 1712/5/2008, New Zealand AKX/02/00/364, 
Manchester, Leeds and London 06/MRE01/98, Cork ECM5 (10)05/02/08) and all women 
provided written informed consent. 
Recruitment of participants to the SCOPE study has previously been described in detail (7). In 
brief, participants were referred from hospital antenatal clinics, obstetricians, general 
practitioners, community midwives or self-referred. Nulliparous women with singleton 
pregnancies were recruited before 15 weeks’ of gestation. Those considered at high risk of 
preeclampsia, SGA or preterm birth because of underlying medical conditions (including 
known pre-existing chronic hypertension on hypertensive medication or with a blood pressure 
>160/100 mmHg at 15 weeks of gestation), gynaecological history, three or more miscarriages 
or terminations of pregnancy or couples who received medical or surgical interventions which 
could modify pregnancy outcome were not eligible. Participants were interviewed at 15 ± 1 
and 20 ± 1 weeks of gestation by SCOPE research midwives. 
Recruited women were excluded from the present analyses if any of the following reasons 
applied: protocol violation, lost to follow up, multiple sexual partners and unsure of the identity 
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of the biological father of the baby and miscarriage or termination (Figure 1). At the 15 ± 1 
weeks’ interview, data collected included demographic information, medical history, previous 
obstetric history, family history of obstetric complications and medical disorders. Current 
pregnancy data included information on any complications during current pregnancy, diet, 
smoking, alcohol and the use of recreational drugs. Each woman’s birthweight and the 
gestational age at which she was born were self-reported and confirmed from clinical records 
or birth registries when possible. The birthweights of 4407 out of 5327 women (82.7%) were 
confirmed from clinical records or birth registries. Maternal physical measurements obtained 
at 15 weeks of gestation included height, weight and blood pressure.  All participants were 
followed prospectively and pregnancy outcome data and infant measurements were recorded 
by research midwives usually within 72 hours of birth.  
 
Definitions of pregnancy outcomes 
Gestational hypertension was defined as systolic blood pressure ≥140 mmHg and/or diastolic 
blood pressure ≥90 mmHg on two or more measurements 6 h apart after 20 weeks of gestation. 
Preeclampsia was defined using the revised ISSHP definition of gestational hypertension or 
postpartum hypertension with proteinuria (24-h urinary protein 300 mg or spot urine protein : 
creatinine ratio ≥30 mg/mmol creatinine or urine dipstick protein ≥++) or any multisystem 
complication of preeclampsia or utero-placental dysfunction as evidenced by intrauterine 
growth restriction (8). Multisystem complications included any of acute renal insufficiency 
defined as a new increase in serum creatinine concentration ≥100 µmol/L antepartum or >130 
µmol/L postpartum; effects on liver, defined as raised aspartate transaminase or alanine 
transaminase concentration, or both, >45 IU/L and/or severe right upper quadrant or epigastric 
pain or liver rupture; neurological effects included eclampsia, imminent eclampsia (severe 
headache with hyper-reflexia and persistent visual disturbance), or cerebral haemorrhage; and 
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haematological effects included thrombocytopenia (platelets <100×109/L), disseminated 
intravascular coagulation, or haemolysis. Small for gestational age (SGA) was defined as a 
birth weight below the 10th customised centile adjusted for maternal height, weight, parity and 
ethnicity, gestational age at delivery and infant sex. Normotensive SGA was defined as birth of 
a SGA infant where the mother did not have hypertension. Spontaneous preterm birth (sPTB) 
was defined as spontaneous preterm labour or preterm premature rupture of membranes 
resulting in a preterm birth at <37 weeks. Gestational diabetes mellitus (GDM) was defined as 
was defined as fasting glucose ≥ 5.1 mmol/L or a 2 h level of  ≥ 8.5 mmol/L following an Oral 
Glucose Tolerance Test, according to the new World Health Organization classification. At the 
time of recruitment of participants to the SCOPE study, the screening procedures for GDM 
were not the same throughout the recruiting centres due to country specific guidelines. 
Therefore, only participants from Adelaide and Auckland were included in all the analyses for 
GDM.  Uncomplicated pregnancy was defined as a pregnancy with no antenatal medical or 
obstetric complications and resulting in the delivery of an appropriately grown, healthy baby 
at ≥ 37 weeks’ of gestation. 
 
Statistics 
Statistical analyses were performed using R version 2.8.0 (cran.r-project.org). The data for 
each pregnancy complication (preeclampsia, gestational hypertension, SGA, spontaneous 
preterm birth and gestational diabetes mellitus) was compared to the uncomplicated pregnancy 
group. Women who reported a birthweight 3000-3499g were considered the reference group 
as the mean birthweights across the recruiting centres were within this range. The risks for 
pregnancy complications for women with a birthweight <2500g, 2500-2999, 3500-3999 and 
≥4000g were compared with the reference group. For categorical variables, Chi-square test was 
used to compare the groups and for continuous variables, student’s t-test was used. Generalized 
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linear mixed models with Logit link was used to estimate odds ratios for each of the measures 
of variable of interest. For each variable, adjusted odds ratios were calculated by adding 
variables to the mixed model and with recruitment centres differences accounted for as a 
random effect. Based on previous literature, established confounders for each pregnancy 
complication were included in the models as follows: for preeclampsia, maternal age, smoking 
at 15 weeks' gestation, ethnicity, socioeconomic status, family history of preeclampsia, 
hypertension in first degree relative, maternal gestational age at birth, infant sex and 
recruitment centre; for gestational hypertension, maternal age, smoking at 15 weeks' gestation, 
ethnicity, socioeconomic status, family history of hypertensive disease of pregnancy, 
hypertension in first degree relative, maternal gestational age at birth, infant sex and 
recruitment centre; for normotensive SGA pregnancy, maternal age, smoking at 15 weeks' 
gestation, ethnicity, socioeconomic status, family history of low birthweight, maternal 
gestational age at birth, infant sex and recruitment centre; for spontaneous preterm birth, 
adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, 
family history of sPTB, maternal gestational age at birth and infant sex and for GDM, maternal 
age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of GDM, 
maternal gestational age at birth, infant sex and recruitment centre. Elevated BMI is a known 
risk factor for most of the above pregnancy complications. Low birthweight is known to lead 
to adult obesity and hence BMI is considered an effect modifier in the relationship between 
birthweight and pregnancy complications. Therefore, we have conducted separate analyses to 
assess the effect of BMI on the association between birthweight and pregnancy complications. 
Results are reported as number and percent [n (%)] or mean ± standard deviation (SD) as 
appropriate. P < 0.05 was considered statistically significant. A retrospective power calculation 
was performed and demonstrated a >90% power to detect a two-fold increase in risk of each 




Of the 5690 pregnant women recruited, 5327 were eligible for this study (figure 1). Amongst 
them, 3200 (60.1%) had uncomplicated pregnancies, 357 (6.7%) had gestational hypertension, 
347 (6.5%) had preeclampsia, 433 (8.1%) had SGA infants in the absence of any hypertensive 
disease of pregnancy (normotensive SGA), 216 (4.1%) had sPTB, 163 (3.1% ) had GDM and 
854 (26.7%) had other medical or obstetric complications (figure 1). Of the Adelaide and 
Auckland SCOPE cohort eligible for this study (n = 1954), 97 women (4.9%) had GDM (figure 
1). 
The characteristics of the participants according to pregnancy outcome are shown in table 1 
and characteristics of the participants according to recruitment centre are shown in 
supplementary table 1. After adjusting for confounders, a birthweight <2500g was associated 
with increased risk of developing preeclampsia (OR = 1.7, 95% CI = 1.0 - 2.9), gestational 
hypertension (OR = 2.2, 95% CI = 1.3 - 3.7), SGA pregnancy (OR = 1.9, 95% CI = 1.1 – 3.2) 
and GDM (OR = 2.4, 95% CI = 1.0 – 5.8) compared to the reference group (table 2).  
We also evaluated whether women’s BMI at 15 weeks’ gestation had an impact on the 
association between their birthweight and risk for pregnancy complications (table 3). Women 
were stratified into 4 groups as follows. Group 1 (reference group),  those who had a 
birthweight ≥ 2500g and remained lean (BMI <25 kg/m2) at the 15 weeks’ visit, Group 2,  those 
who had a birthweight ≥ 2500g and were either overweight or obese (BMI ≥25 kg/m2), Group 
3,  those who had a birthweight <2500g and remained lean (BMI <25 kg/m2) and Group  4,  
those who had a birthweight <2500g and were either overweight or obese (BMI ≥25 kg/m2). 
The risk for pregnancy complications for women in groups 2, 3 and 4 were compared to that 
for women in group 1. After adjusting for confounders, women in group 2 were at increased 
risk for preeclampsia and gestational hypertension, those in group 3 were at increased risk for 
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gestational hypertension and those in group 4 were at increased risk for preeclampsia, 
gestational hypertension and GDM (table 3).  
 
DISCUSSION 
The results herein for this large well defined prospective cohort shows that a woman’s 
birthweight has an effect on her pregnancy and that this effect is modified by her BMI at 15 ± 
1 weeks’ gestation. 
Women who reported a birthweight <2500g were found to be at 1.7 times higher risk of 
preeclampsia compared to those who had a birthweight of 3000 - 3499g. Women who reported 
a birthweight of 3500 - 3999g or a birthweight ≥ 4000g had a 40% reduced risk of preeclampsia 
compared to the control group. When we stratified the cohort based on the woman’s 
birthweight and her BMI at 15 ± 1 weeks’ gestation, no significant risk for preeclampsia was 
seen for women who had a low birthweight but remained lean. The risk of preeclampsia for 
those who had a normal birthweight but became overweight or obese was 1.5 times higher 
compared to those who had a normal birthweight and remained lean. The highest risk for 
preeclampsia (2.3 times increased risk) was seen for women who had a low birthweight and 
subsequently became overweight or obese as adults. These findings confirm the previous 
findings of Dempsey and colleagues (9). We have used the revised ISSHP definition of 
preeclampsia for our analyses which includes women who had gestational hypertension and 
SGA infants in the preeclampsia group. Hence the reported rate of preeclampsia in this paper 
is higher than that reported in previous publications from the SCOPE study. 
Women who reported a low birthweight were at 2.2 times increased risk of developing 
gestational hypertension compared to women who had a normal birthweight. When stratified 
by birthweight and BMI, women who had a low birthweight but remained lean as adults were 
at 1.6 times increased risk of GH, those who had a normal birthweight but were overweight or 
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obese had 3.0 times increased risk of GH and those who had a low birthweight and were 
overweight or obese had 2.2 times increased risk of developing GH compared to the control 
group.  
The causal pathways linking low birthweight with preeclampsia and gestational hypertension 
are yet to be confirmed but a few plausible mechanism have been proposed. Exposure to 
unfavourable conditions in utero have been shown to lead to nephron deficits and renal 
dysfunction by a number of mechanisms. In animal models, altered programming of nephron 
number is shown to be associated with glomerular hypertrophy and reduced renal vascular 
dilation contributing to risk of hypertension (10, 11). Maternal nutritional status during 
pregnancy also plays an important role in fetal programming with malnutrition having adverse 
effects on renal development (10). Additionally, alterations in the renin-angiotensin-
aldosterone system (RAAS) including upregulation or downregulation of specific receptors, 
have also been implicated in the development of renal dysfunction (12). Therefore, those who 
are born with a low birthweight may be “programmed” in utero for later life hypertension. 
When such individuals experience added stresses including an elevated BMI or the 
haemodynamic burden of pregnancy, they may develop gestational hypertension or 
preeclampsia. (13). The mechanism of hypertensive diseases of pregnancy in women born with 
low birthweight could be renal-mediated via programming of the RAAS suggesting a subclass 
of hypertensive diseases in pregnancy. 
Women with a low birth weight were at 1.9 times increased risk of delivering a SGA infant, 
however, when stratified according to birthweight and BMI no significant differences were 
seen between the groups. Fetal growth in utero serves as a marker of many prenatal conditions 
and hence birthweight is influenced by many factors. Heritability accounts for 0.2 – 0.4 for 
variation in birthweight and the mother’s birthweight is shown to be a stronger predictor of 
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offspring birthweight than the father’s birthweight independent of the mother’s adult size (14, 
15).  
Although there was a small increase in risk of sPTB for women who reported a low birthweight 
this association was not significant after adjusting for confounders and woman’s BMI also did 
not have an effect. The multivariable logistic regression models showed that this was mainly 
due to the very strong effect of maternal smoking on the risk for sPTB. Several previous studies 
reported that women who were born with a birthweight <2500g have an increased risk of 
delivering preterm (16-20) while others found no association (21, 22). The disagreement in 
findings could be due to the definition of preterm birth, with some studies including all preterm 
births (spontaneous and medically induced), as well as due to the different confounders that 
have been used in statistical analyses. A previous study that assessed the influence of women’s  
BMI on the association between their birthweight and risk for sPTB reported findings similar 
to ours (20). 
Women who reported a birthweight <2500g were found to be at 2.4 times increased risk of 
GDM compared to the control group and when stratified by birthweight and BMI, those who 
were born with a low birthweight and became overweight or obese were at 3.2 times increased 
risk of GDM compared to the control group. Consistent with our findings, a previous study by 
Seghieri and colleagues also showed that low birthweight among women  
was associated with a two-fold increased risk for GDM after adjusting for age, parity, family 
history of diabetes and pre pregnancy BMI (23). The relationship between low birthweight and 
GDM can also be proposed to be linked to intrauterine programming. It has been postulated 
that growth restricted infants have a reduced number of pancreatic β cells leading to diminished 
capacity to produce insulin which can result in increased risk for diabetes (3, 23).  
The link between exposure to adverse intrauterine conditions resulting in intrauterine growth 
restriction and obesity in adulthood was first shown in birth cohort studies of individuals 
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exposed to the Dutch Famine (24). Since then there has been robust evidence linking low 
birthweight with adult life obesity. Our findings suggest that some women who were born small 
when exposed to the “second hit’ of pregnancy, may experience pregnancy complications.  
We acknowledge that maternal birthweight in 920 (17.3%) women in our study was self- 
reported and hence could be influenced by recall bias. We also did not have pre-pregnancy 
BMI in these women and used BMI data obtained at 15 ± week’s gestation. Although weight 
gain during the first 15 weeks of pregnancy is usually minimal, some women gain substantial 
weight in early pregnancy and some women lose weight during this period. Since we did not 
have data on pre-pregnancy BMI, we could not assess early pregnancy weight gain/loss which 
can influence pregnancy outcome (25). Hence we acknowledge this limitation. However, the 
availability of data on a large number of variables enabled us to correct for many important 
confounding factors. 
Overall, the main finding of this study is that women who are born with a low birthweight and 
subsequently become overweight or obese appear to be at increased risk for developing 
gestational hypertension, preeclampsia and GDM. Many modifiable environmental and life 
style factors contribute to the risk of pregnancy complications. Further studies assessing the 
influence of such factors including diet and exercise on the relationship between low 
birthweight and pregnancy complications may yield important results on whether modifiable 
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Data sharing: The SCOPE study, which commenced recruitment in 2004, did not seek specific 
consent from participants for sharing their data publicly. However, the SCOPE Consortium 
Scientific Advisory Board invites applications to use the collected data via email to the 
chairperson, Amy Aherne at amy.aherne@ucc.ie. Applicants will be asked to complete a 
Research Application Form specifying details for their planned study which will then be 
reviewed by the SCOPE Scientific Advisory Board. The SCOPE Consortium is keen to 
promote collaboration among researchers and to see our unique SCOPE database and 
pregnancy biobank used in studies which meet our ethics and consenting process. The SCOPE 
consortium is a member of the International Pregnancy Collaboration 
(https://pregnancycolab.tghn.org/) and has participated in several studies involving shared data. 
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Missing maternal birthweight measurement (n=292) 
Study population 


















gestational age  

































# Includes 14 spontaneous preterm birth (SPTB) and SGA, 11 SPTB and preeclampsia, 12 sPTB and GDM. ^ Includes 18 gestational diabetes 
(GDM) and PE, 12 GDM and SPTB. $ These included any pregnancy that was not completely uncomplicated but were not complicated by any of 
the major pregnancy complications and included those requiring admission to hospital for other significant medical or surgical conditions, 


























Table 1 Characteristics of the study population 
 
  Uncomplicated Preeclampsia P value GH P value  SGA P value sPTB P value Uncomplicated* GDM* P value 
  (N = 3200) (N = 347)   (N = 357)   (N = 433)   (N = 216)   (N = 1857) (N = 97)   
Age (years) 28.8 ± 5.3 28.2 ± 5.8 0.06 28.6 ± 5.29 0.28 28.4 ± 5.7 0.11 28.5 ± 5.8 0.71 28.2 ± 5.6 29.0 ± 5.4 0.17 












Caucasian 2948 (92.1%) 319 (91.9%)  338 (94.7%)  390 (90.1%)  203 (93.9%)  1667 (89.8%) 80 (82.5%)  








60 (3.2%) 1 (1.0%) 
 
Asian 85 (2.7%) 5 (1.4%)  1 (0.28%)  11 (2.5%)  1 (0.5%)  73 (3.9%) 6 (6.2%)  
Indian 54 (1.7%) 7 (2.02%)  5 (1.4%)  10 (2.3%)  8 (3.7%)  31 (1.7%) 9 (9.3%)  
Other 52 (1.6%) 7 (2.02%)  3 (0.8%)  13 (3%)  3 (1.4%)  26 (1.4%) 1 (1.0%)  
             
Gravidity   0.76  0.06  0.06  <0.001   0.14 
1 2508 (78.4%) 268 (77.2%)  298 (83.5%)  319 (73.7%)  150 (69.4%)  1407 (758%) 65 (67.0%)  
2 542 (16.9%) 64 (18.4%)  49 (13.7%)  93 (21.5%)  44 (20.4%)  341 (18.4%) 25 (25.9%)  
≥ 3 150 (4.7%) 15 (4.3%)  10 (2.8%)  21 (4.8%)  22 (10.2%)  109 (5.9%) 7 (7.2%)  
             
At 15 ± 1 weeks          
 
  
Smoking 291 (9.1%) 35 (10.1%) 0.61 32 (8.9%) 1 91 (21.02%) <0.001 36 (16.7%) <0.001 163 (8.8%) 8 (8.3%) 1 
Body mass index (kg/m2) 24.8 ± 4.3 27.9 ± 6.3 <0.001 27.8 ± 5.5 <0.001 25.1 ± 4.9 0.52 25.6 ± 5.4 0.1 25.0 ± 4.6 30.4 ± 6.8 <0.001 
SBP (mmHg) 105 ± 10 113 ± 11 <0.001 113 ± 10 <0.001 107 ± 10 0.07 108 ± 11 0.006 106 ± 10 114 ± 13 <0.001 
DBP (mmHg) 64 ± 7 70 ± 8 <0.001 70 ± 8 <0.001 65 ± 8 0.33 66 ± 8 0.02 63.5 ± 7.7 70.1 ± 9.5 <0.001 
             
Pregnancy outcome 
         
 
  
Gestation at delivery (wks) 40.2 ± 1.1 38.3 ± 2.7 <0.001 39.8 ± 1.6 0.001 39.3 ± 3.2 <0.001 34.2 ± 3.4 <0.001 40.1 ± 1.2 38.5 ± 2.2 <0.001 
Birthweight (g) 3591 ± 397 2934 ± 734 <0.001 3515 ± 475 0.002 2694 ± 517 <0.001 2387 ± 721 <0.001 3588 ± 398 3320 ± 657 <0.001 
Birthweight centile 54 ± 25 31 ± 31 <0.001 50 ± 27 0.001 5 ± 3 <0.001 49 ± 31 0.02 54 ± 25 53 ± 32 0.6 
                          
 
Results are expressed as mean ± SD or N (%). All p values are for comparison of complicated pregnancy group with uncomplicated. SBP, systolic blood 
pressure; DBP, diastolic blood pressure 
* Data from Adelaide and Auckland SCOPE cohort only  
 





Table 2 Association between maternal weight at birth and pregnancy complications 
 
 
Risk for pregnancy Maternal birthweight 
complications <2500g 2500-2999g 3000-3499g 3500-3999 ≥4000 
Uncomplicated n (%) 154 (4.8) 533 (16.7) 1281 (40.0) 934 (29.2) 298 (9.3) 
Preeclampsia n (%) 30 (8.6) 78 (22.5) 150 (43.2) 67 (19.3) 22 (6.3) 
OR (95% CI) 1.6 (1.0 - 2.5) 1.2 (0.9 - 1.6) 1 0.6 (0.5 - 0.8) 0.6 (0.4 - 1.0) 
aOR (95% CI) 1.7 (1.0 - 2.9) 1.2 (0.9 - 1.7) 1 0.6 (0.5 - 0.9) 0.6 (0.4 - 1.0) 
GH n (%) 28 (7.8) 74 (20.7) 127 (35.6) 97 (27.2) 31 (8.7) 
OR (95% CI) 1.8 (1.2 - 2.9) 1.4 (1.0 - 1.9) 1 1.0 (0.8 - 1.4) 1.0 (0.7 - 1.5) 
aOR (95% CI) 2.2 (1.3 - 3.7) 1.4 (1.1 - 2.0) 1 1.0 (0.8 - 1.4) 1.0 (0.6 - 1.5) 
SGA n (%) 36 (8.3) 110 (25.4) 169 (39.0) 98 (22.6) 20 (4.6) 
OR (95% CI) 1.7 (1.2 - 2.6) 1.5 (1.2 - 2.0) 1 0.8 (0.6 - 1.0) 0.5 (0.3 - 0.8) 
aOR (95% CI) 1.9 (1.1 - 3.2) 1.6 (1.2 - 2.1) 1 0.8 (0.6 - 1.0) 0.5 (0.3 - 0.8) 
sPTB n (%) 20 (9.3) 37 (17.1) 88 (40.7) 54 (25.0) 17 (7.9) 
OR (95% CI) 1.8 (1.1 - 3.1) 1.0 (0.7 - 1.5) 1 0.8 (0.6 - 1.2) 0.8 (0.5 - 1.4) 
aOR (95% CI) 1.3 (0.7 - 2.4) 0.9 (0.6 - 1.3) 1 0.9 (0.6 - 1.2) 0.8 (0.5 - 1.4) 
*Uncomplicated n (%) 96 (5.2) 316 (17.0) 737 (39.7) 543 (29.2) 165 (8.9) 
*GDM n (%) 11 (11.3) 24 (24.7) 39 (40.2) 16 (16.5) 7 (7.2) 
OR (95% CI) 2.0 (1.0 - 4.1) 1.4 (0.8 - 2.3) 1 0.6 (0.3 - 1.1) 0.8 (0.4 - 1.9) 










Preeclampsia adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of preeclampsia, hypertension in 
first degree relative, maternal gestational age at birth, infant sex and recruitment centre 
Gestational hypertension (GH) adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of hypertensive 
disease of pregnancy, hypertension in first degree relative, maternal gestational age at birth, infant sex and recruitment centre 
SGA adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of low birthweight, maternal gestational age 
at birth, infant sex and recruitment centre 
Spontaneous preterm (sPTB) birth adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of sPTB, 
maternal gestational age at birth, infant sex and recruitment centre 
Gestational diabetes mellitus (GDM) adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of diabetes, 
maternal gestational age at birth, infant sex and recruitment centre 





      
      
      
 
 
       
     
     




Risk for pregnancy 
Maternal birthweight (g) / BMI (kg/m2) 
 ≥ 2500g, <25 kg/m2 (Gp 1)  ≥ 2500g,  ≥ 25 kg/m2 (Gp 2) <2500g, <25 kg/m2 (Gp 3) <2500g, ≥ 25 kg/m2 (Gp 4) 
Uncomplicated n (%) 1882 (58.81) 1164 (36.38) 86 (2.69) 68 (2.12) 
Preeclampsia n (%) 114 (32.85) 203 (58.5) 11 (3.17) 19 (5.48) 
OR (95% CI) 1 2.9 (2.3 - 3.7) 2.1 (1.1 - 4.1) 4.6 (2.7 - 7.9) 
aOR (95% CI) 1 1.5 (1.04 – 2.02) 2.0 (0.9 – 4.1) 2.3 (1.2 – 4.5) 
GH n (%) 112 (31.37) 217 (60.78) 13 (3.64) 15 (4.2) 
OR (95% CI) 1 3.1 (2.5 - 3.9) 2.5 (1.4 - 4.7) 3.7 (2.1 - 6.7) 
aOR (95% CI) 1 1.6 (1.1 – 2.2) 3.0 (1.6 – 5.9) 2.2 (1.1 – 4.5) 
SGA n (%) 109 (50.46) 87 (40.28) 9 (4.17) 11 (5.09) 
OR (95% CI) 1 1.1 (0.9 - 1.4) 1.9 (1.1 - 3.1) 1.9 (1.1 - 3.3) 
aOR (95% CI) 1 1.0 (0.7 – 1.4) 1.5 (0.8 - 2.8) 1.4 (0.7 – 2.9) 
sPTB n (%) 234 (54.04) 163 (37.64) 20 (4.62) 16 (3.7) 
OR (95% CI) 1 1.3 (0.9 - 1.7) 1.8 (0.9 - 3.7) 2.8 (1.4 - 5.4) 
aOR (95% CI) 1 0.9 (0.6 – 1.4) 1.3 (0.6 – 2.8) 1.4 (0.6 – 3.2) 
Uncomplicated n (%) 1049 (56.49) 712 (38.34%) 54 (2.91) 42 (2.26) 
GDM n (%) 25 (25.77) 61 (62.89) 1 (1.03) 10 (10.31) 
OR (95% CI) 1 3.6 (2.2 – 5.8) 0.78 (0.1 – 5.8) 9.9 (4.5 - 22.1) 
aOR (95% CI) 1 0.9 (0.5 – 1.9) 0.8 (0.1 – 1.9) 3.2 (1.1 – 9.5) 
 
Preeclampsia adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of preeclampsia, hypertension in 
first degree relative, maternal gestational age at birth, infant sex and recruitment centre  
Gestational hypertension (GH) adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of hypertensive 
disease of pregnancy, hypertension in first degree relative, maternal gestational age at birth, infant sex and recruitment centre 
SGA adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of low birthweight, maternal gestational age 
at birth, infant sex and recruitment centre 
Spontaneous preterm (sPTB) birth adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of sPTB, 
maternal gestational age at birth, infant sex and recruitment centre 
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Gestational diabetes mellitus (GDM) adjusted for maternal age, smoking at 15 weeks' gestation, ethnicity, socioeconomic status, family history of diabetes, 
maternal gestational age at birth, infant sex and recruitment centre 





















































Age (years): Mean (SD) 23.8 (5.1) 31.1 (4.7) 28.3 (5.5) 29.8 (4.5) 30.4 (4.7) 26.1 (5.6) 28.7 (5.4) 
Ethnicity: N(%)        
Caucasian 1019 (95.1) 149 (81.9) 263 (85.9) 1675 (98.0) 1644 (85.7) 128 (91.4) 4878 (91.6) 
Polynesian 5 (0.5) 1 (0.5) 0 (0.0) 0 (0.0) 96 (5.0) 0 (0.0) 102 (1.9) 
Asian 19 (1.8) 6 (3.3) 7 (2.3) 5 (0.3) 91 (4.7) 1 (0.7) 129 (2.4) 
Indian 3 (0.3) 7 (3.8) 15 (4.9) 19 (1.1) 64 (3.3) 5 (3.6) 113 (2.1) 
Other 26 (2.4) 19 (10.4) 21 (6.9) 10 (0.6) 23 (1.2) 6 (4.3) 105 (2.0) 
Gravidity: N(%)        
1 790 (73.7) 126 (69.2) 220 (71.9) 1443 (84.4) 1446 (75.4) 102 (72.9) 4127 (77.5) 
2 212 (19.8) 43 (23.6) 70 (22.9) 228 (13.3) 366 (19.1) 25 (17.9) 944 (17.7) 
≥ 3 70 (6.5) 13 (7.1) 16 (5.2) 38 (2.2) 106 (5.5) 13 (9.3) 256 (4.8) 
Woman’s reported birthweight 
(g):Mean (SD) 
3240.2 (585.1) 3251.1 (537.0) 3266.2 (531.4) 3360.6 (534.9) 3314.2 (537.7) 3277.0 (504.1) 3308.3 (547.1) 
Woman’s reported gestational age at 
delivery (weeks): Mean (SD) 
39.4 (2.1) 39.6 (1.9) 39.6 (1.9) 39.9 (1.5) 39.9 (1.9) 39.8 (1.5) 39.8 (1.8) 
        
At 15 ± 1 weeks        
Smoking: N(%) 252 (23.5) 8 (4.4) 33 (10.8) 172 (10.1) 71 (3.7) 30 (21.4) 566 (10.6) 
Body mass index (kg/m2): Mean (SD) 27.2 (6.6) 24.4 (3.8) 25.1 (4.8) 24.9 (4.2) 24.8 (4.2) 25.2 (5.1) 25.3 (4.9) 
SBP (mmHg): Mean (SD) 109.7 (10.2) 104.2 (9.0) 104.5 (9.0) 105.6 (10.3) 106.7 (10.5) 110.0 (13.0) 106.8 (10.5) 
DBP (mmHg): Mean (SD) 64.5 (8.0) 65.2 (7.0) 63.7 (6.8) 66.7 (7.3) 64.5 (8.2) 65.2 (8.4) 65.2 (7.8) 
        
Pregnancy outcome        
Gestation at delivery (weeks): Mean 
(SD) 39.3 (2.7) 39.8 (2.4) 39.8 (2.5) 39.8 (2.0) 39.5 (2.5) 40.3 (1.8) 39.6 (2.4) 
Birthweight (g): Mean (SD) 3334.8 (662.2) 3381.4 (592.1) 3340.9 (611.1) 3438.7 (567.7) 3406.4 (611.3) 3386.4 (550.4) 3397.2 (607.3) 
Birthweight centile: Mean (SD) 46.1 (29.5) 45.5 (29.5) 42.7 (28.6) 48.5 (29.5) 48.4 (28.9) 38.7 (29.1) 47.3 (29.3) 
PE: N(%) 108 (10.1) 7 (3.8) 12 (3.9) 104 (6.1) 101 (5.3) 15 (10.7) 347 (6.5) 
GHTN: N(%) 90 (8.4) 6 (3.3) 11 (3.6) 161 (9.4) 89 (4.6) 0 (0.0) 357 (6.7) 
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SGA: N(%) 87 (8.1) 14 (7.7) 40 (13.1) 119 (7.0) 149 (7.8) 24 (17.1) 433 (8.1) 
sPTB: N(%) 59 (5.5) 6 (3.3) 12 (3.9) 54 (3.2) 81 (4.2) 4 (2.9) 216 (4.1) 
GDM: N(%) * 55 (2.8) 0 (0.0) 0 (0.0) 0 (0.0) 42 (2.1) 0 (0.0) 97 (4.9) 
* % of Adelaide and Auckland 
(N=1954)        
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